Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
CRISPR-scanning could lead to more effective treatments for cancer

CRISPR-scanning could lead to more effective treatments for cancer

Research reveals genomic basis of acute erythroid leukemia

Research reveals genomic basis of acute erythroid leukemia

New Australian drug trial achieves remarkable results in patients with acute myeloid leukemia

New Australian drug trial achieves remarkable results in patients with acute myeloid leukemia

Scientists find highly promising therapeutic target for leukemia

Scientists find highly promising therapeutic target for leukemia

Study discovers new therapy for aggressive blood cancer

Study discovers new therapy for aggressive blood cancer

Leukemia promotes premature aging in the bone marrow

Leukemia promotes premature aging in the bone marrow

New drug compounds show promise in treating acute myeloid leukemia

New drug compounds show promise in treating acute myeloid leukemia

New study extends our knowledge of the link between miRNAs and cancer

New study extends our knowledge of the link between miRNAs and cancer

Researchers discover mechanism which drives leukemia cell growth

Researchers discover mechanism which drives leukemia cell growth

Scientists discover two therapies that slow progression of pediatric leukemia in mice

Scientists discover two therapies that slow progression of pediatric leukemia in mice

Active ingredient in eye drops shows promise for treating aggressive blood cancer

Active ingredient in eye drops shows promise for treating aggressive blood cancer

Research advances offer hope for patient-tailored AML treatment

Research advances offer hope for patient-tailored AML treatment

Research highlights ability of Bio-Rad's ddPCR in quantifying minimal residual disease

Research highlights ability of Bio-Rad's ddPCR in quantifying minimal residual disease

Cleveland Clinic expert develops personalized prediction model for Myelodysplastic Syndromes

Cleveland Clinic expert develops personalized prediction model for Myelodysplastic Syndromes

FDA approves new combination therapy for acute myeloid leukemia

FDA approves new combination therapy for acute myeloid leukemia

DNA mutations in healthy and leukemic blood stem cells do not differ, shows research

DNA mutations in healthy and leukemic blood stem cells do not differ, shows research

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

FDA approves new treatment for AML patients

FDA approves new treatment for AML patients

St. Jude Hospital announces availability of largest collections of leukemia samples

St. Jude Hospital announces availability of largest collections of leukemia samples

Researchers unravel mystery of NPM1 protein in acute myeloid leukemia

Researchers unravel mystery of NPM1 protein in acute myeloid leukemia